WHO ICTRP trial
Real world study of Bladder Cancer patients in India
CTRI/2024/06/068713 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/06/068713 |
|---|---|
| Public title | Real world study of Bladder Cancer patients in India |
| Scientific title | Real-World Treatment Patterns and Clinical Outcomes Among Patients with Urothelial Carcinoma (UC) in India - NIL |
| Primary sponsor | Pfizer Products India Private Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Countries | India |
| Conditions | Health Condition 1: N33- Bladder disorders in diseases classified elsewhere |
| Interventions | Control Intervention1: none: none |
| Registration date | Nov 6, 2024 |
| Target size | 300 |
| Secondary IDs | B8011015 version 1 dated 22 August 2023 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: